Publication | Closed Access

Dexfenfluramine discontinuous treatment does not worsen hypoxia-induced pulmonary vascular remodeling but activates RhoA/ROCK pathway: Consequences on pulmonary hypertension

Hypoxia-induced Pulmonary VascularHypertensionPulmonary Arterial HypertensionPulmonary CirculationCardiovascular DiseaseMedicineDexfenfluramine Discontinuous TreatmentPulmonary PhysiologyPulmonary PharmacologyPulmonary HypertensionVascular BiologyPulmonary MedicinePharmacotherapyPublic HealthPharmacologyPulmonary Vascular DiseaseAnesthesiology